Press Release Nicox Provides Third Quarter 2022 Financial and Business Highlights Topline results of the NCX 470 Mont Blanc Phase 3 glaucoma trial due in.
Press Release Nicox Announces Last Patients Complete Final Visit in NCX 470 Phase 3 Mont Blanc Glaucoma Trial The last patients completed their final (3-month) visit on September 16691 patients
Press Release Nicox to Participate in Financial and Scientific Events in Q3 2022August 3, 2022 – release at 7:30 am CET Sophia Antipolis, FranceNicox SA.